{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3639, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/2", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/3", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide outlines the status of THIO-101, 102, and 103 trials and mentions specific patent filings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/4", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style layout to map drug candidates against clinical development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/5", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "79eac8b2-69eb-42cc-94c1-b5b70805ff28", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 5-6 discuss the current state of cancer treatment and its limitations", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/6", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "79eac8b2-69eb-42cc-94c1-b5b70805ff28", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 5-6 discuss the current state of cancer treatment and its limitations", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/7", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 introduce THIO and its mechanisms of action", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "why_now", "function": "establish_context", "notes": "The slide uses a three-column layout with circular callouts to present demographic and health statistics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/8", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-8", "loopMatches": [ { "to": 9, "from": 8, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "ccc33018-f447-48b1-a7ff-aad25768e4d1", "evidence": "Slides 8-9 discuss the current state of cancer treatment and the need for new solutions", "position": 1, "objective": "Why is now the right time for THIO?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 introduce THIO and its mechanisms of action", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "thesis_headline", "function": "establish_context", "notes": "This slide serves as a transition or key message reinforcement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/9", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-9", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" }, { "to": 9, "from": 8, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "ccc33018-f447-48b1-a7ff-aad25768e4d1", "evidence": "Slides 8-9 discuss the current state of cancer treatment and the need for new solutions", "position": 1, "objective": "Why is now the right time for THIO?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 introduce THIO and its mechanisms of action", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a visual comparison between telomere targeting (left) and PD-1/PD-L1 checkpoint inhibition (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/10", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-10", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 introduce THIO and its mechanisms of action", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "Slide highlights a strategic partnership/supply agreement as a form of business traction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/11", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-11", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/12", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-12", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a clinical trial process flow including randomization and expansion phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/13", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-13", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/14", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-14", "loopMatches": [ { "to": 14, "from": 9, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "efef3358-ed9b-42fa-8406-e83983de324a", "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials", "position": 0, "objective": "Is THIO effective in clinical trials?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.7, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights that THIO has a better safety profile than standard chemotherapy, which typically has 70-80% incidence of Grade 3-5 side effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/15", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "comparison_table", "function": "compare_peers", "notes": "DCR stands for Disease Control Rate. The table compares historical clinical trial data (KEYNOTE 024, REVEL, RWD) against the company's own THIO-101 trial data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/16", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Data presented in a table format with specific clinical definitions for DCR and treatment lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/17", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "DCR = Disease Control Rate. Data presented in three separate tables for different dose cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/18", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "Clinical trial data visualization showing patient-level outcomes over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/19", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/20", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/21", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "solution", "function": "present_solution", "notes": "The slide shows a biological mechanism of action (MOA) validation using a dot plot to show TIFs increase over 72 hours.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/22", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/23", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "why_now", "function": "show_traction", "notes": "The slide presents two line charts showing tumor volume reduction and long-term survival/rechallenge success.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/24", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table compares three treatment regimens across four categories: Expected Efficacy, Safety Profile, Administration, and Trial of Reference.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/25", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table compares historical standard of care data against planned THIO-102 trial outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/26", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "comparison_table", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/27", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "traction", "function": "show_traction", "notes": "The slide presents two line charts showing tumor volume reduction over time for different treatment regimens in SCLC and HCC mouse models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/28", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a clear divergence between the control group (increasing tumor volume) and the THIO group (decreasing tumor volume to near zero).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/29", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "traction", "function": "show_traction", "notes": "The slide shows two line charts representing tumor volume over time in HCC models, highlighting the efficacy of THIO and THIO+Libtayo combinations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/30", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a clinical trial process flow from initial baskets through immune activation to a pivotal phase.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/31", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "unfair_advantage", "function": "other", "notes": "The slide highlights both regulatory NCE exclusivity and a specific count of issued/pending patents.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/32", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "team_bio", "function": "other", "notes": "Includes a logo grid at the bottom representing past affiliations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/33", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "26b12bcb-8bf2-4572-a596-8ab619393b64", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 33-34 present the management team and capitalization table", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes details on options, warrants, and insider ownership percentage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/34", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "26b12bcb-8bf2-4572-a596-8ab619393b64", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 33-34 present the management team and capitalization table", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/35", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart compares the $42B combined market of major CPIs against a $0.5B figure, likely representing the company's specific asset or segment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/36", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 37, "from": 36, "beatId": "1d30a812-8762-4566-a2e0-8faa0ba1b8c4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 36-37 discuss the market opportunity and comparable companies", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a logo-grid and metric-grid to establish valuation context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/37", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 37, "from": 36, "beatId": "1d30a812-8762-4566-a2e0-8faa0ba1b8c4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slides 36-37 discuss the market opportunity and comparable companies", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a growth curve background to imply value accumulation over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/38", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "traction", "function": "show_traction", "notes": "The slide serves as a milestone marker for the company's public listing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/39", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/LNwYpTbA8B6lfabFKQprwZVth2nNljqmIP9yVlgR73c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNmM2NjUwOGFhMTEzYjI2ODUxZTE2ZTYxMmUxZDA0Yy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/1", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/M7UjbDUAfx5P0ZWuaFfCtjTgLwQhGIQy99kxFYZN2Fg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNmM2NjUwOGFhMTEzYjI2ODUxZTE2ZTYxMmUxZDA0Yy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/_N57vamomC_BgmW4UqKDXjq2N9HChLCS0Ue3OuiPPwc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNmM2NjUwOGFhMTEzYjI2ODUxZTE2ZTYxMmUxZDA0Yy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/LL6jWOMvwsP_X1ZSZQ003KOy08YOu8Xwb21k0R9lKo0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNmM2NjUwOGFhMTEzYjI2ODUxZTE2ZTYxMmUxZDA0Yy9wMDAxLnBuZw" }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/2", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/3", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/4", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/5", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "product_demo", "function": "present_solution", "notes": "Includes a process diagram for the test workflow and product imagery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/6", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "b2e6d101-bc6e-475a-b6ca-16fad428f8d6", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The document presents a product demo on page 6", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The slide outlines the technical workflow from sample collection (FIT tube and DNA stabilization tube) through analysis to the final patient report.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/7", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents clinical validation data for the ColoAlert diagnostic test.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/8", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a 3-column layout to categorize achievements by strategic pillar.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/9", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "2eec5995-07f0-40c1-b673-685e2791019a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents commercialization achievements on page 9", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "cover", "function": "front_matter", "notes": "The slide features a minimalist design with a corporate logo and a halftone dot pattern.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/10", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a visual timeline/process flow to explain the disease progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/11", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-11", "loopMatches": [ { "to": 12, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "65c6d63c-5d6a-4a99-909a-65517b4e456c", "evidence": "The document presents a problem statement and highlights the benefits of early detection", "position": 0, "objective": "To highlight the importance of early CRC detection and the consequences of inaction", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 11, "beatId": "09af3d83-0f8f-43f3-aa10-3a4b1e3b6499", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a clear problem statement on page 11", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "analyze_data", "notes": "AA = Advanced Adenoma; CRC = Colorectal Cancer. Data sourced from JNCI 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/12", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-12", "loopMatches": [ { "to": 12, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "65c6d63c-5d6a-4a99-909a-65517b4e456c", "evidence": "The document presents a problem statement and highlights the benefits of early detection", "position": 0, "objective": "To highlight the importance of early CRC detection and the consequences of inaction", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow to demonstrate the technical workflow of the diagnostic test.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/13", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 13, "beatId": "eae162b8-118c-4a2c-b74c-1eea0303300f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a clear solution on page 13", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "timeline", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/14", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "The slide features a thumbnail of a scientific poster presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/15", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "product_demo", "function": "present_solution", "notes": "The slide outlines a multi-step diagnostic process involving FIT analysis and proprietary DNA/mRNA extraction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/16", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides clinical trial data breakdown for a diagnostic product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/17", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a highlighted box emphasizing the primary performance metrics for CRC and AA detection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/18", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses two scatter plots to compare diagnostic performance metrics against competitors like Guardant Health, Cologuard, and CellMax Life.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/19", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-19", "loopMatches": [ { "to": 20, "from": 19, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "35fffa56-7968-429c-bf10-755f823eda7c", "evidence": "The document presents a competitive analysis on page 19", "position": 1, "objective": "To provide a competitive analysis and demonstrate the advantages of Mainz Biomed's solution", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 19, "from": 19, "beatId": "ddb86a32-9146-428c-9aba-e55500ab5892", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides a competitive analysis on page 19", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/20", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-20", "loopMatches": [ { "to": 20, "from": 19, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "35fffa56-7968-429c-bf10-755f823eda7c", "evidence": "The document presents a competitive analysis on page 19", "position": 1, "objective": "To provide a competitive analysis and demonstrate the advantages of Mainz Biomed's solution", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "roadmap", "function": "plan_implementation", "notes": "Includes a footer note about future feasibility studies for other tests.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/21", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-05a8-756d-90c0-05335f3877b6", "docSlug": "06c66508aa113b26851e16e612e1d04c", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 28 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-05a8-756d-90c0-05335f3877b6/22", "deckHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6", "deckAnchorHref": "/decks/019de076-05a8-756d-90c0-05335f3877b6#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }